IL-1RN and IL-1 β Polymorphism and ARV-Associated Hepatotoxicity
- PMID: 29849489
- PMCID: PMC5911319
- DOI: 10.1155/2018/4398150
IL-1RN and IL-1 β Polymorphism and ARV-Associated Hepatotoxicity
Abstract
The severity of hepatic injury depends upon cytokines. Previous studies associated IL-1RN allele 2 with IL-1β production. Hence, we examined the association of IL-1 RN and IL-1β polymorphisms with ARV-associated hepatotoxicity. Genotyping of IL-1RN (VNTR), IL-1β (-511C/T) polymorphisms was done in 162 HIV-infected patients, 34 with ARV hepatotoxicity, 128 without hepatotoxicity, and 152 healthy controls using PCR and PCR-RFLP method. The haplotypes 1T and 2C enhanced the risk for severe hepatotoxicity (OR = 1.41, P = 0.25; OR = 1.67, P = 0.31). IL-1β-511TT genotype significantly represented among tobacco using HIV-infected individuals compared to nonusers (OR = 3.74, P = 0.05). IL-1β-511TT genotype among alcohol users increased the risk for hepatotoxicity (OR = 1.80, P = 0.90). IL-1β-511CT and -511TT genotypes overrepresented in alcohol using HIV-infected individuals (OR = 2.29, P = 0.27; OR = 2.64, P = 0.19). IL-RN 2/2 and 1/3 genotypes represented higher in nevirapine using hepatotoxicity patients (OR = 1.42, P = 0.64, OR = 8.79, P = 0.09). IL-1β-511CT and -511 TT genotypes among nevirapine users enhanced the risk for severe hepatotoxicity (OR = 4.29, P = 0.20; OR = 1.95, P = 0.56). IL-1β-511CT and -511TT genotypes were overrepresented in combined nevirapine and alcohol using HIV-infected individuals as compared to nevirapine users and alcohol nonusers (OR = 2.56, P = 0.26; OR = 2.84, P = 0.24). IL-1β-511TT genotype with tobacco, alcohol, and nevirapine usage revealed a trend of risk for the development of ARV-associated hepatotoxicity and its severity.
Similar articles
-
Genetic variants of interleukin-1RN and interleukin-1beta genes and risk of cervical cancer.BJOG. 2008 Apr;115(5):633-8. doi: 10.1111/j.1471-0528.2007.01655.x. BJOG. 2008. PMID: 18333945
-
Genetic association of interleukin-1beta (-511C/T) and interleukin-1 receptor antagonist (86 bp repeat) polymorphisms with Type 2 diabetes mellitus in North Indians.Clin Chim Acta. 2007 Feb;377(1-2):163-9. doi: 10.1016/j.cca.2006.09.012. Epub 2006 Oct 27. Clin Chim Acta. 2007. PMID: 17069782
-
Occurrence of Interleukin-2 (330 G/T) Promoter Polymorphism in ARV associated hepatotoxicity.Curr Mol Med. 2019;19(3):206-215. doi: 10.2174/1566524019666190411093451. Curr Mol Med. 2019. PMID: 30973108
-
CYP1A1m1 and CYP2C9*2 and *3 polymorphism and risk to develop ARV-associated hepatotoxicity and its severity.APMIS. 2017 Jun;125(6):523-535. doi: 10.1111/apm.12683. Epub 2017 Apr 3. APMIS. 2017. PMID: 28370504
-
Interleukin-1B polymorphisms and gastric cancer risk--a meta-analysis.Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1920-8. doi: 10.1158/1055-9965.EPI-06-0267. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 17035400 Review.
Cited by
-
ABCG2 polymorphisms and susceptibility to ARV-associated hepatotoxicity.Mol Genet Genomic Med. 2024 Mar;12(3):e2362. doi: 10.1002/mgg3.2362. Epub 2024 Mar 7. Mol Genet Genomic Med. 2024. PMID: 38451012 Free PMC article.
-
Anakinra and hepatotoxicity in pediatric rheumatology: a case series.Pediatr Rheumatol Online J. 2023 Oct 6;21(1):112. doi: 10.1186/s12969-023-00891-y. Pediatr Rheumatol Online J. 2023. PMID: 37803456 Free PMC article.
-
Mechanistic insights into antiretroviral drug-induced liver injury.Pharmacol Res Perspect. 2020 Aug;8(4):e00598. doi: 10.1002/prp2.598. Pharmacol Res Perspect. 2020. PMID: 32643320 Free PMC article. Review.
-
Evaluation of Drug-Induced Liver Injury in Hospitalized Patients with SARS-CoV-2 Infection.Microorganisms. 2022 Oct 17;10(10):2045. doi: 10.3390/microorganisms10102045. Microorganisms. 2022. PMID: 36296321 Free PMC article.
References
-
- McGovern B. Hepatic safety and HAART. Journal of the International Association of Physicians in AIDS Care. 2004;3(Supplement 2):S24–S40. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources